New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareIGF-1 DES vs Somatropin (HGH)

IGF-1 DES vs Somatropin (HGH)

Side-by-side comparison of key properties, dosing, and research.

Anabolic & IGF
IGF-1 DES
Growth Hormone PeptidesAnti-Aging & Longevity
Somatropin (HGH)
Summary
IGF-1 DES (also written DES(1-3)IGF-1) is a truncated form of IGF-1 missing the first three amino acids of the N-terminus. This structural change dramatically reduces its affinity for IGF binding proteins (IGFBPs), meaning a far greater fraction remains in its free, active form. IGF-1 DES is estimated to be 10x more potent than standard IGF-1 LR3 at the receptor level locally, making it particularly effective for site-specific muscle growth when injected intramuscularly.
Somatropin is recombinant human growth hormone (rhGH), identical in structure to the 191-amino acid pituitary-derived growth hormone. It is FDA-approved for growth hormone deficiency, short stature, and wasting conditions. Off-label, it is widely explored for body composition, anti-aging, and performance enhancement, though significant risks accompany unsupervised use.
Half-Life
~20–30 minutes (very short — designed for local action)
2-3 hours (subcutaneous); 20-30 minutes (intravenous)
Admin Route
IM, SubQ
Subcutaneous, Intramuscular (less common)
Research
Typical Dose
20–50 mcg per injection site
0.15-0.3 mg/day (adults); titrated to IGF-1 levels
Frequency
Once daily, post-workout
Once daily
Key Benefits
  • Estimated 10x greater potency at the receptor vs IGF-1 LR3 locally
  • Minimal IGFBP binding — nearly all active upon injection
  • Highly localized muscle growth effect when injected intramuscularly
  • Activates satellite cells for muscle fiber hyperplasia potential
  • Synergistic with GH peptides in post-workout anabolic protocols
  • Shorter half-life reduces systemic exposure vs IGF-1 LR3
  • Useful for site-specific muscle development
  • Increases lean muscle mass and reduces body fat (particularly visceral)
  • Restores growth hormone deficiency (FDA-approved)
  • Improves bone mineral density
  • Enhances exercise capacity and recovery
  • Supports skin thickness and collagen synthesis
  • Improves lipid profile in GHD patients
  • Explored for anti-aging and cellular regeneration
Side Effects
  • Hypoglycemia (most significant risk — especially post-workout)
  • Localized muscle swelling at injection site
  • Potential for jaw/organ growth (acromegalic effects) with prolonged high-dose use
  • Carpal tunnel syndrome with high doses
  • +1 more
  • Fluid retention and edema (common, dose-dependent)
  • Carpal tunnel syndrome
  • Joint and muscle pain
  • Insulin resistance and elevated blood glucose
  • +3 more
Stacks With